News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.

Breaking Down the Standard of Care for Patients With Polycythemia Vera

ByDr. Marina Kremyanskaya

November 26th 2025

Image of Sue

A Tribute to My Friend With Cancer

November 26th 2025

Image of woman.

Quitting Smoking After Cancer Diagnosis Can Add Another Year of Life

November 26th 2025

Image of a woman

PV Patient Advocate Welcomes Treatment Advancement Through Clinical Trial

November 26th 2025

Image of lung.

How Vaccines Can Partner With Immunotherapy to Treat Lung Cancer

November 25th 2025

Trending on CURE

How New Therapies Are Changing the Game for Small Cell Lung Cancer

FDA Approves Imfinzi Plus Chemo in GC/GEJC

A Cancer Survivor's Thanksgiving Reflection

Understanding Triple-Negative Breast Cancer Care

Breaking Down the Standard of Care for Patients With Polycythemia Vera

© 2025 MJH Life Sciences^®

All rights reserved.